Results 41 to 50 of about 952,046 (252)
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Osteosarcoma (OS) and Ewing sarcoma (EWS) are the most common primary bone cancers in children, but acute thrombosis is poorly characterized in this population. Our study evaluated the rates of venous thromboembolism (VTE) and associated risk factors in pediatric patients with bone sarcomas treated over a 10‐year period encompassing
Sarah Kappa +8 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Children with acute lymphoblastic leukemia (ALL) are at risk of severe outcomes from SARS‐CoV‐2 (SCV2). In the post‐pandemic context, where most children have been infected with SCV2, there are limited data on whether vaccination remains beneficial in children with ALL.
Janna R. Shapiro +11 more
wiley +1 more source
The log dose dependent curve of Compound 18 and 21 against DENV-2 NS2B/NS3pro.
, 2019 The log dose dependent curve of Compound 18 and 21 against DENV-2 NS2B/NS3pro.
Ezatul Ezleen Kamarulzaman (6260978) +11 more
core +1 more source
, 2021 This paper describes our continued efforts in the area of small-molecule apelin receptor agonists. Recently disclosed compound 2 showed an acceptable metabolic stability but demonstrated monodemethylation of the dimethoxyphenyl group to generate ...
Peter S. Gargalovic (7865195) +25 more
core +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background An internal tandem duplication in the gene encoding Fms‐like tyrosine kinase 3 (FLT3‐ITD) is associated with high relapse risk and poor prognosis in acute myeloid leukemia (AML) and plays a crucial role in treatment decisions. Measurable residual disease (MRD) analysis of FLT3‐ITD during and after treatment has shown prognostic ...
Sofie Johansson Alm +11 more
wiley +1 more source
4-Bromo-2-(5-bromothiophen-2-yl)-1-[(5-bromothiophen-2-yl)methyl]-5,6-dimethyl-1H-benzimidazole
Acta Crystallographica Section E, 2014 The title compound, C18H13Br3N2S2, was obtained via the reaction of N-bromosuccinamide with 5,6-dimethyl-2-(thiophen-2-yl)-1-[(thiophen-2-yl)methyl]-1H-benzimidazole.
H. Cristina Geiger +2 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Claudin‐6 has emerged as a promising immunotherapeutic target, yet protein‐level data in atypical teratoid/rhabdoid tumors (AT/RTs) have been inconsistent. We analyzed 36 well‐characterized AT/RT samples and found membranous claudin‐6 protein expression in 58% of cases, with striking enrichment in the molecular subgroup AT/RT‐TYR (100%) and ...
Victoria E. Fincke +4 more
wiley +1 more source
AT2R Agonist, Compound 21, Is Reno-Protective Against Type 1 Diabetic Nephropathy
, 2015 The hemodynamic and nonhemodynamic effects of angiotensin lion diabetic complications are considered to be primarily mediated by the angiotensin II type 1 receptor subtype. However, its biological and functional effect mediated through the angiotensin II
Jandeleit-Dahm, Karin A. +15 more
core +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Wilms tumor (WT) treatment imposes a significant time burden on patients and their families. Time toxicity is a patient‐centered metric that quantifies the burden of healthcare interaction. We sought to define time toxicity in the first year after diagnosis of WT and hypothesized that it would increase as tumor stage and treatment ...
Caleb Q. Ashbrook +6 more
wiley +1 more source
Rhenium(I) Tricarbonyl Complexes of 5,10,15,20-Tetraphenyl-21-thia and 21-Oxaporphyrins
, 2016 The hexa-coordinated rhenium(I) tricarbonyl complexes of 5,10,15,20-tetraphenyl-21-thiaporphyrin 1 and 5,10,15,20-tetraphenyl-21-oxaporphyrin 2 have been synthesized by thermal reaction of corresponding free base porphyrin with Re2(CO)10.
Mangalampalli Ravikanth (1559524) +1 more
core +5 more sources